FIELD: medicine.
SUBSTANCE: what is presented is the use of bacteria of the strains Lactobacillus rhamnosus, Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium breve able to stimulate the development of initial bifidogenic intestinal microbiota in preparing a probiotic composition for reducing a risk of developing overweight or future obesity in a nursing infant wherein the probiotic is prescribed during a perinatal and/or postnatal period in dose 103-1012 CFU.
EFFECT: what is presented is reducing a body weight index in 4-year-old children taken the probiotics during the perinatal period vs placebo.
10 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING STRAIN Bifidobacterium lactis CNCM I-3446 IN CHILDREN DELIVERED BY CESAREAN SECTION (VERSIONS) AND PROBIOTIC COMPOSITION CONTAINING ABOVE STRAIN (VERSIONS) | 2008 |
|
RU2521500C2 |
| SYNBIOTIC MIXTURE | 2007 |
|
RU2448720C2 |
| BABY MIXTURE CONTAINING PROBIOTICS | 2006 |
|
RU2428886C2 |
| PROBIOTICS FOR IMPROVING TgA SECRETION IN INFANTS BORN BY CAESAREAN SECTION | 2009 |
|
RU2496505C2 |
| SINBIOTIC FOR IMPROVING INTESTINAL MICROBIOTA | 2008 |
|
RU2456008C2 |
| ADDITIVE TO MATERNAL RATION | 2008 |
|
RU2464995C2 |
| NUTRITIONAL COMPOSITION CONTAINING OLIGOSACCHARIDES MIXTURE | 2009 |
|
RU2508743C2 |
| PREBIOTICS FOR REDUCING RISK OF DEVELOPING OBESITY IN LATER LIFE | 2015 |
|
RU2699981C2 |
| INFANT FORMULA WITH PROBIOTICS AND MILK FAT GLOBULE MEMBRANE COMPONENTS | 2010 |
|
RU2563355C2 |
| USING LACTOBACILLUS REUTERI FOR RECOVERING MICROBIOTA AFTER DYSBIOSIS AT EARLY STAGES OF DEVELOPMENT | 2015 |
|
RU2723687C2 |
